The Manitowoc Company just reported its worst quarter in recent memory — and the stock still gained 6%.
Q1 2026 delivered a clear miss. Adjusted EPS came in at -$0.13 against a $0.04 consensus estimate, a $0.17 shortfall. Revenue of $494.6 million trailed the $516.6 million forecast by $22 million. On the surface, that is the kind of print that triggers a flush. Instead, management held full-year guidance — affirming FY2026 adjusted EPS of $0.45–$0.90 and sales of $2.25–$2.35 billion — and the market took comfort. The stock closed at $13.67, up 6.4% on the day and 2.2% on the week, recovering a full month of losses in a single session after the after-market release.
The positioning picture heading into earnings was strikingly unbothered for a company with a challenging print looming. Short interest has been climbing — up roughly 25% over the past month to 3.7% of the free float — but the absolute level is still modest enough that shorts were never a dominant force on this name. Borrow costs have jumped materially, more than tripling from under 0.6% to 1.83% over the past 30 days, a signal that demand for borrow was building. Despite that, availability remains generous, indicating no meaningful squeeze pressure was in place ahead of the release. Options positioning told the same low-tension story: the put/call ratio of 0.035 is near multi-month lows, well below its 52-week high of 1.28, suggesting options traders carried no meaningful hedges into the print. The ORTEX short score of 39.8 places MTW in a broadly neutral zone — below the 50th percentile.
The Street was already lined up skeptically before the results landed. Both Barclays and Wells Fargo carry Underweight ratings on the stock, with Barclays trimming its target to $11 on April 1st after previously holding at $13. The mean analyst target of $10.50 sat well below the pre-print price level — implying the analyst consensus return potential is negative 23%. That is a striking gap: the stock at $13.67 trades a full 30% above where the average covering analyst thinks it belongs. Baird holds a Neutral rating (the sole non-negative view in the coverage group) with a target that has drifted lower over successive quarters. The EPS surprise factor score of just 4 (out of 100) reflects a chronic pattern of missing estimates. Note that these analyst targets are from March 31 — they will likely shift materially following today's print, and any post-earnings revisions will be the clearest near-term signal on whether the consensus gap closes or widens.
The ownership table carries one genuinely notable entry. CEO Aaron Ravenscroft sold 50,584 shares in a two-day cluster on February 25–27 at prices around $14.69–$14.75, generating roughly $744,000. The CFO and multiple senior executives sold alongside him in what reads as a coordinated plan-based disposal. Ravenscroft simultaneously holds 526,650 shares as a registered institutional holder, keeping significant skin in the game. The February sales occurred at prices above today's trading level — and prior to a quarter that missed badly — a detail worth noting even if the sales appear routine.
Among correlated peers, PLOW was the standout mover this week, gaining 13.8% on the day and 12.3% on the week — comfortably outpacing MTW's 6.4% daily gain. ASTE and OSK also posted modest gains, while PH slipped 9.3% on the week. The sector tone was constructive enough to provide a tailwind, though MTW's move appears driven by its own guidance reassurance rather than a sector-wide bid.
The next question is whether the Street upgrades its view after the guidance hold, or whether the persistent EPS miss pattern keeps analysts anchored to their Underweight targets. Watch for analyst revisions in the coming days — that is where the post-earnings story on MTW will actually be written.
See the live data behind this article on ORTEX.
Open MTW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
